The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology 2025 (Videos + Slides)

Overview

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology 2025 (Videos + Slides) provides an expert-led online CME program designed to reinforce essential hematology knowledge. This comprehensive course covers critical topics including molecular genetics, leukemia, lymphomas, bone marrow disorders, and transfusion medicine to support clinical decision-making and board exam preparation.

On-demand oncology & hematology education — accessible anytime, anywhere.

Agenda

This course offers a detailed review of current hematology concepts, presented by leading experts. Topics include fundamental mechanisms, diagnosis, and treatment strategies relevant to hematologic malignancies and disorders.

• Molecular Genetics of Cancer — Marios Giannakis, MD, PhD
• Infections in Cancer Patients — Lindsey Baden, MD
• Opioid Prescribing for Cancer-Related Pain — Kate M. Lally, MD
• Communication – The Key to Excellence in End-of-Life Care — Eilann C. Santo, MD, MPH
• Biology of Hematopoietic Stem Cell Transplantation — Robert J. Soiffer, MD
• Biology of Acute Leukemia and Myelodysplastic Syndromes — Zuzana Tothova, MD, PhD
• The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now — Daniel J. DeAngelo, MD, PhD
• Myelodysplastic Syndrome — Eric S. Winer, MD
• Chronic Myelogenous Leukemia — Marlise R. Luskin, MD
• Myeloproliferative Syndromes — Joan-Chi How, MD
• Multiple Myeloma — Kenneth C. Anderson, MD
• Waldenstrom Macroglobulinemia and Amyloidosis — Jorge J. Castillo, MD
• Low Grade Lymphomas — Caron A. Jacobson, MD
• Aggressive Non-Hodgkin Lymphoma Part 1 – Diffuse Large B-Cell and Burkitt — Eric D. Jacobsen, MD
• Aggressive Non-Hodgkin Lymphoma Part 2 – Mantle Cell and T-Cell — Eric D. Jacobsen, MD
• Hodgkin’s Lymphoma — Reid W. Merryman, MD
• Diagnosis and Treatment of CLL and Related B-Cell Malignancies — Matthew S. Davids, MD
• Hematopoiesis and Cytokines — David B. Sykes, MD, PhD
• Acquired Bone Marrow Failure — Julie-Aurore Losman, MD, PhD
• Congenital Bone Marrow Failure — Grant Rowe, MD, PhD
• HLH — Sarah Nikiforow, MD
• Anemia – An Overview — Robert Stern, MD
• Iron Deficiency and Iron Overload — Mark D. Fleming, MD, Dphil
• Immune Hemolytic Anemia — Arielle L. Langer, MD, MPH
• Non-immune Hemolytic Anemia — David E. Golan, PhD, MD
• Sickle Cell Disease — Maureen M. Achebe, MD, MPH
• Thalassemia and Other Hemoglobinopathies — Matthew M. Heeney, MD
• Disorders of Neutrophils — Nancy Berliner, MD
• Acquired Thrombocytopenias — Elisabeth M. Battinelli, MD, PhD
• Hemophilia — Stacy E. Croteau, MD
• Von Willebrand Disease and Congenital Platelet Disorders — Nathan T. Connell, MD, MPH
• Congenital and Acquired Thrombophilia — Kenneth A. Bauer, MD
• Managing Challenging Cases of Venous Thrombosis in Patients with Cancer — Jean M. Connors, MD
• Transfusion Medicine for the Clinician — Marie A. Hollenhorst, MD, PhD

Speakers

• Marios Giannakis, MD, PhD
• Lindsey Baden, MD
• Kate M. Lally, MD
• Eilann C. Santo, MD, MPH
• Robert J. Soiffer, MD
• Zuzana Tothova, MD, PhD
• Daniel J. DeAngelo, MD, PhD
• Eric S. Winer, MD
• Marlise R. Luskin, MD
• Joan-Chi How, MD
• Kenneth C. Anderson, MD
• Jorge J. Castillo, MD
• Caron A. Jacobson, MD
• Eric D. Jacobsen, MD
• Reid W. Merryman, MD
• Matthew S. Davids, MD
• David B. Sykes, MD, PhD
• Julie-Aurore Losman, MD, PhD
• Grant Rowe, MD, PhD
• Sarah Nikiforow, MD
• Robert Stern, MD
• Mark D. Fleming, MD, Dphil
• Arielle L. Langer, MD, MPH
• David E. Golan, PhD, MD
• Maureen M. Achebe, MD, MPH
• Matthew M. Heeney, MD
• Nancy Berliner, MD
• Elisabeth M. Battinelli, MD, PhD
• Stacy E. Croteau, MD
• Nathan T. Connell, MD, MPH
• Kenneth A. Bauer, MD
• Jean M. Connors, MD
• Marie A. Hollenhorst, MD, PhD

Target Audience

This course is designed for hematologists, oncologists, internal medicine physicians, hematology fellows, and other healthcare professionals seeking to update and strengthen their expertise in hematology. It is also relevant for clinicians preparing for board certification or recertification exams in hematology.

Why This Topic Matters

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology 2025 (Videos + Slides) addresses critical advances and core concepts in hematology, supporting clinicians in maintaining current knowledge essential for quality patient care. This comprehensive review facilitates the reinforcement of fundamental principles and emerging therapies in oncology and hematology.

Accessed via MedHub Central, this program provides a reliable resource for hematology professionals who aim to enhance clinical competence and exam readiness. The focused hematology content aligns well with the clinical demands of specialists managing complex hematologic conditions.